SeaCrest Wealth Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

SeaCrest Wealth Management’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-500	Closed	-$3K	–	2313
2018 Q4	$3K	Sell	500 -1,000	-67%	-$7.37K	﹤0.01%	1877
2018 Q3	$16K	Sell	1,500 -500	-25%	-$5.37K	﹤0.01%	1487
2018 Q2	$22K	Sell	2,000 -5,000	-71%	-$45K	﹤0.01%	1330
2018 Q1	$56K	Hold	7,000	–	–	0.01%	911
2017 Q4	$57K	Buy	+7,000	New	+$47.4K	0.01%	909

Other funds holding CEMI

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

SeaCrest Wealth Management's CEMI Position: Q1 2019 in Review

SeaCrest Wealth Management sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2019, closing a stake of 500 shares — an estimated $3K sold.

SeaCrest Wealth Management first reported a position in CEMI in Q4 2017 and held it in 5 quarters. The position peaked at $57K in Q4 2017. 39 funds tracked by Wall St. Rank hold CEMI as of Q1 2019.

SeaCrest Wealth Management reported no remaining Chembio diagnostics, Inc. position as of Q1 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 500 Chembio diagnostics, Inc. shares in Q1 2019, an estimated $3K.
SeaCrest Wealth Management first reported a position in Chembio diagnostics, Inc. in Q4 2017 and held it in 5 quarters.
SeaCrest Wealth Management's Chembio diagnostics, Inc. position peaked at $57K in Q4 2017.
39 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2019.

Based on SeaCrest Wealth Management's 13F filing for Q1 2019, filed 10 May 2019.